Welcome to our dedicated page for Futuris Co news (Ticker: FTRS), a resource for investors and traders seeking the latest updates and insights on Futuris Co stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Futuris Co's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Futuris Co's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Futuris Company (OTC Pink: FTRS) has announced the acquisition of Physical Therapy Rehab Associates (PTRA), enhancing its Health HR platform. Based in Broward County, Florida, PTRA has served Home Health partners since 2003. This acquisition adds six Home Health clients and licensed therapists to Health HR. The 4th quarter saw a 16% increase in gross revenue. Going forward, Health HR aims to integrate PTRA's clients and staff while pursuing additional strategic acquisitions in South Florida. The company is also focusing on recruiting quality staff and launching a marketing campaign in the Miami-Dade area to expand its client base.
Futuris Company (OTC Pink: FTRS) announced an upcoming webinar titled "A Covert Weapon for Litigators" in collaboration with The TASA Group, scheduled for January 18, 2023. The session will focus on duty and standard of care investigations, leveraging Forensic Business Pathology techniques that have achieved a 96% success rate in over 40 cases. Tom Taormina, an experienced consultant and witness, will lead the presentation. The event aims to provide valuable insights for legal professionals.
Futuris Company (OTC Pink: FTRS) has announced the acquisition of LotusUSA, Inc., a leading consultancy in resourcing for US Government and Federal Agencies. This strategic acquisition focuses on enhancing Futuris's capabilities in Information Technology and Healthcare.
LotusUSA has extensive experience, having executed over 326 contracts with various government agencies, and is recognized for its role in improving efficiency and responsiveness in supply chains. This acquisition positions Futuris to capitalize on its existing presence in California and expand its service offerings.
FAQ
What is the current stock price of Futuris Co (FTRS)?
What is the market cap of Futuris Co (FTRS)?
